Our data that in addition to EGF, CHD6 is also upregulated by Wnt signaling support the exploration of Cetuximab in combination with Wnt inhibitor in treating CRC exhibiting high CHD6 expression. The gene discussed is CHD6; the disease is colorectal carcinoma.